| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 255 |
| 1 | NALOXONE HYDROCHLORIDE | 75 |
| 2 | NALOXONE HYDROCHLORIDE NASAL | 68 |
| 3 | DIMETHYL FUMARATE | 25 |
| 4 | OXYCODONE | 19 |
| 5 | PREDNISONE | 19 |
| 6 | ERGOCALCIFEROL | 18 |
| 7 | NATALIZUMAB | 17 |
| 8 | ASPIRIN | 15 |
| 9 | ASPIRIN 325 MG | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPYLHEXEDRINE | 1 | 0.0172 |
| 1 | PRAZIQUANTEL | 1 | 0.0033 |
| 2 | SUTIMLIMAB-JOME | 1 | 0.0031 |
| 3 | RESLIZUMAB | 2 | 0.0029 |
| 4 | POLIDOCANOL | 4 | 0.0027 |
| 5 | RESMETIROM | 6 | 0.0026 |
| 6 | SEBETRALSTAT | 1 | 0.0019 |
| 7 | CAPLACIZUMAB | 3 | 0.0017 |
| 8 | BEXAROTENE | 2 | 0.0015 |
| 9 | MENTHOL AND METHYL SALICYLATE | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 255 |
| 1 | Corticosteroid [EPC] | 40 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 3 | Benzodiazepine [EPC] | 20 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 18 |
| 5 | Provitamin D2 Compound [EPC] | 18 |
| 6 | Integrin Receptor Antagonist [EPC] | 17 |
| 7 | Opioid Agonist [EPC] | 16 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 9 | Interferon beta [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Sclerosing Agent [EPC] | 3 | 0.0067 |
| 2 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 3 | Thyroid Hormone Receptor beta Agonist [EPC] | 6 | 0.0026 |
| 4 | Prostacycline [EPC] | 1 | 0.0011 |
| 5 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 6 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 7 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 255 | 0.0005 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |